Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Masjuan

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Cerebrovascular Diseases Extra|November 11, 2020
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 PatientsVictoria Ros-Castelló, Elena Natera-Villalba, Ana Gómez-López, et al.
International Journal of Molecular Sciences|December 17, 2024
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis PatientsRaquel Sainz-Amo, Alexander Rodero-Romero, Enric Monreal, et al.
Stroke|May 1, 2024
Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKEChih-Hao Chen, Ashkan Shoamanesh, Pablo Colorado, et al.
Vaccines|September 28, 2023
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 VaccineAlexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, et al.
Frontiers in Immunology|September 3, 2024
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosisRaquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, et al.
Stroke|July 30, 2011
Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient dataJosé M Ferro, Isabelle Crassard, Jonathan M Coutinho, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated SyndromeEnric Monreal, Susana Sainz de la Maza, Lucienne Costa-Frossard, et al.
Stroke Research and Treatment|August 1, 2012
Intravenous thrombolytic treatment in the oldest oldJuan García-Caldentey, María Alonso de Leciñana, Patricia Simal, et al.
Scientific Reports|April 30, 2021
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatmentPaulette Esperanza Walo-Delgado, Susana Sainz de la Maza, Noelia Villarrubia, et al.
Journal of Comparative Effectiveness Research|September 23, 2022
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registriesFrancisco Marin, Marcelo Sanmartín Fernández, Iñaki Lekuona, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Cerebrovascular Diseases Extra|November 11, 2020
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 PatientsVictoria Ros-Castelló, Elena Natera-Villalba, Ana Gómez-López, et al.
International Journal of Molecular Sciences|December 17, 2024
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis PatientsRaquel Sainz-Amo, Alexander Rodero-Romero, Enric Monreal, et al.
Stroke|May 1, 2024
Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKEChih-Hao Chen, Ashkan Shoamanesh, Pablo Colorado, et al.
Vaccines|September 28, 2023
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 VaccineAlexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, et al.
Frontiers in Immunology|September 3, 2024
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosisRaquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, et al.
Stroke|July 30, 2011
Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient dataJosé M Ferro, Isabelle Crassard, Jonathan M Coutinho, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated SyndromeEnric Monreal, Susana Sainz de la Maza, Lucienne Costa-Frossard, et al.
Stroke Research and Treatment|August 1, 2012
Intravenous thrombolytic treatment in the oldest oldJuan García-Caldentey, María Alonso de Leciñana, Patricia Simal, et al.
Scientific Reports|April 30, 2021
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatmentPaulette Esperanza Walo-Delgado, Susana Sainz de la Maza, Noelia Villarrubia, et al.
Journal of Comparative Effectiveness Research|September 23, 2022
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registriesFrancisco Marin, Marcelo Sanmartín Fernández, Iñaki Lekuona, et al.
Pageof 11